Algorhythm Regains Nasdaq Compliance Amidst Severe Internal Control Weaknesses & Major Dilution
RIME sits 35% above its 52-week low of $0.538 on light trading volume (0.1× avg).
Summary
Algorhythm Holdings regained Nasdaq equity compliance but disclosed severe internal control weaknesses and persistent going concern doubt, with a significant increase in shares outstanding from dilutive financing.
Key Events · Financing and Capital Events · RIME
-
Nasdaq Listing Compliance Regained
The company reported stockholders' equity of $3.168 million as of March 31, 2026, exceeding the Nasdaq minimum requirement of $2.5 million, a critical step for continued listing.
-
Material Weaknesses in Internal Controls
Management concluded that disclosure controls and internal control over financial reporting are not effective due to insufficient accounting resources, lack of segregation of duties, and inability to detect material misstatements in revenue.
-
Significant Share Dilution
Shares outstanding increased by over 330% from 3.4 million at December 31, 2025, to 14.65 million at March 31, 2026, primarily from the settlement of pre-paid purchase agreements.
-
Persistent Going Concern Doubt
The company continues to express substantial doubt about its ability to continue as a going concern for at least one year, citing recurring operating losses and decreasing working capital.
Analysis · RIME · Technology
This quarterly report provides a critical update on Algorhythm Holdings' financial health, confirming a return to Nasdaq equity compliance, which is a short-term positive. However, this was achieved through substantial share dilution. More concerning are the explicit disclosures of material weaknesses in internal controls over financial reporting, indicating fundamental issues with financial oversight. The company also reiterates its "going concern" doubt, highlighting ongoing operational challenges and a reliance on further financing. While cash reserves have increased, the underlying business continues to burn cash, and a recent debt default (though temporarily resolved by a forbearance agreement, as previously disclosed) underscores the precarious financial position.
How filings like this one have moved
In the 30 days to Oct 20, 2026, 37.4% of the 952 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.87%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, RIME was trading at $0.72 on NASDAQ in the Technology sector, with a market capitalization of approximately $10.2M. The 52-week trading range was $0.54 to $4.58. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.